openPR Logo

Press Releases from Novalung GmbH (9 total)

NovaPort twin, the Newest Double-Lumen Cannula, Approved

Novalung adds the unique double-lumen cannula to its expanding portfolio of products for the extrapulmonary treatment of lung failure. Now only a single cannula is required instead of two. Novalung announced today that it has received approval for the new NovaPort twin® double-lumen cannula, which is now available for clinical use. The NovaPort® twin cannula was specifically designed for veno-venous vascular access for the iLA activve® system - the Allrounder for

Novalung receives CE mark for iLA activve®

Novalung receives CE mark for iLA activve® With the new all-rounder for extrapulmonary lung support Novalung GmbH is the only company worldwide offering the complete portfolio for both pumpless and pump-driven lung support. Novalung announces receiving CE mark approval for their new pump-driven iLA activve® lung support system. It will be launched in Europe with immediate effect. Respiratory support with iLA activve® enables a treatment environment with awake, mobile patients instead

Novalung and Medos start cooperation

Due to the acquisition of Medos Medizintechnik AG by the private equity fund Zukunftsfonds Heilbronn (“Future Fund of Heilbronn”) the company will cooperate closely in the future with Novalung GmbH, which is expected to strengthen both medical device companies. The Zukunftsfonds Heilbronn (zfhn) announced that it has acquired Medos Medizintechnik AG from Ventizz Capital Partners Advisory AG. The purchase agreement was signed on January 7, 2011. With this

Josef Bogenschuetz joins Novalung as Managing Director

Novalung GmbH prepares for further growth with former Maquet CEO. As of January 1, 2011, Josef Bogenschütz and Dr. Georg Matheis are joint Managing Directors of Novalung GmbH. Bogenschütz will be specifically responsible for Research & Development, Manufacturing, Quality Management and Finance. This addition underscores the company’s focus on the ongoing and efficient expansion of its portfolio of innovative products designed to replace invasive mechanical ventilation. Nicholas L. Strout remains responsible

Novalung GmbH continues expansion into Scandinavia

The world’s first pumpless lung assist device, the iLA Membrane Ventilator®, now exclusively available in Sweden and Norway through Vingmed Group. Novalung GmbH, the German manufacturer of the world’s leading therapeutic system for extrapulmonary lung support, has signed exclusive agreements with Vingmed Svenska AB and Vingmed AS for distribution of the iLA Membrane Ventilator® in Sweden and Norway, respectively. Dr. Torsten Rinne, Medical Director of Novalung GmbH, noted: “We have seen

Novalung records 50% growth

The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance. Additional financing will allow the Talheim (Germany) based company to accelerate the development of new products. Novalung GmbH increased sales by 50% in 2009. The positive trend continues through the first months of 2010. The increasing acceptance of the company’s innovative therapies for lung failure both in Germany and abroad is driving continuing growth. Manufacturing

Novalung signs Carestream Medical, Inc., as exclusive distributor in Canada

Company intensifies its North American marketing activities to meet increasing demand in the Canadian market Novalung GmbH, the German manufacturer of the innovative iLA Membrane Ventilator® for extrapulmonary lung support, is pleased to announce that it has appointed Carestream Medical, Inc., as its exclusive distributor in Canada. “Carestream is uniquely positioned to represent our products in the Canadian market”, said Dr. Georg Matheis, CEO of Novalung. “With their highly skilled team

Presentation of latest clinical data: Invitation to the scientific symposium

During the 19th Bremer Symposium of Intensive Care latest clinical user data of the iLA Membrane Ventilator® will be presented. These data enable new therapy chances for acute and chronic pulmonary patients. From 18th till 20th February 2009 the 19th Symposium of Intensive Care will take place in Bremen, Germany. We would like to turn your special attention to the symposium “Perspectives beyond protective ventilation” which will take place on Friday,

Novalung Academy moved

Collaboration of the Novalung Academy and the University Hospital Frankfurt will be intensified After the successful relocation of the Novalung headquarters in summer 2008 to Talheim/Germany, the Novalung Academy now also moved from Offenbach to Talheim. Due to the relocation the Novalung Academy is able to intensify its cooperation with the University Hospital Frankfurt. So the theoretical part of the course “protective ventilation strategies” will take place in the congress center “Hoffmanns-Höfe”

Go To Page:   1 2 3 4 5 6 7 8 9 10